Status:
UNKNOWN
Uterovaginal Plexus Block With Articaine for Intrauterine Device Placement Patients Who Are Indicated for the Use of Copper IUD as a Contraceptive Method Will be Invited to Participate in This Research.
Lead Sponsor:
Universidade do Vale do Sapucai
Conditions:
Contraception
IUD
Eligibility:
FEMALE
20-40 years
Phase:
PHASE4
Brief Summary
The use of intrauterine device (IUD) in Brazil is still not very significant and one of the reasons is the fear of feeling pain during its insertion procedure. Articaine is an amide-linked local anest...
Detailed Description
Currently, 55% of pregnancies in Brazil are classified as unwanted and approximately only 3% of women use long-term contraception. Intrauterine devices (IUD) are among the most effective long-acting r...
Eligibility Criteria
Inclusion
- \- Female patients, aged between 20 and 40 years
Exclusion
- Diabetes (type I or II)
- Chronic Kidney
- Urogenital infections
- Psychiatric disesas
- Surgery during the study period
Key Trial Info
Start Date :
February 1 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 10 2022
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05252117
Start Date
February 1 2021
End Date
December 10 2022
Last Update
February 23 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Universidade do Vale do Sapucaí
Pouso Alegre, Minas Gerais, Brazil, 37550000